As 2025 unfolds, a growing number of cancer patients in the USA are rejecting conventional chemotherapy in favor of alternative therapies. Among the most talked-about are the combinations of Ivermectin and Niclosamide, often stacked with Fenbendazole in what's being dubbed the anti-cancer parasite protocol trend 2025. With a surge in interest